169 related articles for article (PubMed ID: 32640956)
1. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
[TBL] [Abstract][Full Text] [Related]
2. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
[TBL] [Abstract][Full Text] [Related]
4. Application of conjugated estrogen cream in the treatment of postmenopausal atrophic vaginitis.
Li D; Bai W
Pak J Pharm Sci; 2018 Sep; 31(5(Special)):2283-2286. PubMed ID: 30463825
[TBL] [Abstract][Full Text] [Related]
5. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
[TBL] [Abstract][Full Text] [Related]
6. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women.
Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W
Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740
[TBL] [Abstract][Full Text] [Related]
8. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.
Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L;
Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260
[TBL] [Abstract][Full Text] [Related]
9. Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial.
Vaccaro CM; Mutema GK; Fellner AN; Crisp CC; Estanol MV; Kleeman SD; Pauls RN
Female Pelvic Med Reconstr Surg; 2013; 19(1):34-9. PubMed ID: 23321657
[TBL] [Abstract][Full Text] [Related]
10. Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial.
Poordast T; Ghaedian L; Ghaedian L; Najib FS; Alipour S; Hosseinzadeh M; Vardanjani HM; Salehi A; Hosseinimehr SJ
J Ethnopharmacol; 2021 Apr; 270():113760. PubMed ID: 33383112
[TBL] [Abstract][Full Text] [Related]
11. The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.
Manonai J; Theppisai U; Suthutvoravut S; Udomsubpayakul U; Chittacharoen A
J Obstet Gynaecol Res; 2001 Oct; 27(5):255-60. PubMed ID: 11776507
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.
Chen J; Geng L; Song X; Li H; Giordan N; Liao Q
J Sex Med; 2013 Jun; 10(6):1575-84. PubMed ID: 23574713
[TBL] [Abstract][Full Text] [Related]
13. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.
Marx P; Schade G; Wilbourn S; Blank S; Moyer DL; Nett R
Maturitas; 2004 Jan; 47(1):47-54. PubMed ID: 14706765
[TBL] [Abstract][Full Text] [Related]
14. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
15. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
[TBL] [Abstract][Full Text] [Related]
16. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial.
Fernandes T; Costa-Paiva LH; Pedro AO; Baccaro LF; Pinto-Neto AM
Menopause; 2016 Jul; 23(7):792-8. PubMed ID: 27116462
[TBL] [Abstract][Full Text] [Related]
18. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.
Tseng LH; Wang AC; Chang YL; Soong YK; Lloyd LK; Ko YJ
Neurourol Urodyn; 2009; 28(1):47-51. PubMed ID: 19089890
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]